601 related articles for article (PubMed ID: 27440935)
1. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
2. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
[TBL] [Abstract][Full Text] [Related]
5. Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction.
Reindl M; Tiller C; Holzknecht M; Lechner I; Henninger B; Mayr A; Brenner C; Klug G; Bauer A; Metzler B; Reinstadler SJ
JAMA Netw Open; 2020 Jun; 3(6):e207030. PubMed ID: 32539151
[TBL] [Abstract][Full Text] [Related]
6. Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients.
Bochaton T; Lassus J; Paccalet A; Derimay F; Rioufol G; Prieur C; Bonnefoy-Cudraz E; Crola Da Silva C; Bernelin H; Amaz C; Espanet S; de Bourguignon C; Dufay N; Cartier R; Croisille P; Ovize M; Mewton N
PLoS One; 2021; 16(1):e0245684. PubMed ID: 33507957
[TBL] [Abstract][Full Text] [Related]
7. Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
Lechner I; Reindl M; Tiller C; Holzknecht M; Fink P; Plangger J; Mayr A; Klug G; Bauer A; Reinstadler SJ; Metzler B
Int J Cardiol; 2022 Aug; 361():1-6. PubMed ID: 35533756
[TBL] [Abstract][Full Text] [Related]
8. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
[TBL] [Abstract][Full Text] [Related]
9. Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.
Sharif D; Abu-Salem M; Sharif-Rasslan A; Rosenschein U
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):632-639. PubMed ID: 27069068
[TBL] [Abstract][Full Text] [Related]
10. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction.
Stiermaier T; Pöss J; Eitel C; de Waha S; Fuernau G; Desch S; Thiele H; Eitel I
Clin Res Cardiol; 2018 Nov; 107(11):1013-1020. PubMed ID: 29766285
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients.
Bulluck H; Nicholas J; Crimi G; White SK; Ludman AJ; Pica S; Raineri C; Cabrera-Fuentes HA; Yellon D; Rodriguez-Palomares J; Garcia-Dorado D; Hausenloy DJ
Int J Cardiol; 2017 Mar; 230():149-154. PubMed ID: 28038815
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity C-reactive protein is associated with worse infarct healing after revascularized ST-elevation myocardial infarction.
Tiller C; Reindl M; Holzknecht M; Lechner I; Simma F; Schwaiger J; Mayr A; Klug G; Bauer A; Reinstadler SJ; Metzler B
Int J Cardiol; 2021 Apr; 328():191-196. PubMed ID: 33309637
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
Aggarwal S; Xie F; High R; Pavlides G; Porter TR
J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.
Kim D; Choi DH; Kim BB; Choi SW; Park KH; Song H
J Clin Lab Anal; 2016 Nov; 30(6):930-940. PubMed ID: 27075615
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
16. Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Theurl M; Basic D; Eigler C; Holzknecht M; Mair J; Mayr A; Klug G; Metzler B
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018020
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
Lønborg J; Engstrøm T; Ahtarovski KA; Nepper-Christensen L; Helqvist S; Vejlstrup N; Kyhl K; Schoos MM; Ghotbi A; Göransson C; Bertelsen L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Kløvgaard L; Høfsten DE; Køber L; Kelbæk H;
J Am Coll Cardiol; 2017 Jun; 69(23):2794-2804. PubMed ID: 28595694
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Mueller L; Koch C; Mayr A; Theurl M; Kirchmair R; Klug G; Metzler B
Heart; 2017 Jun; 103(11):856-862. PubMed ID: 27979879
[TBL] [Abstract][Full Text] [Related]
20. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
